Two Sigma Securities, LLC Alaunos Therapeutics, Inc. Transaction History

Two Sigma Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.04 - $0.13 $5,343 - $17,366	133,592 Added 313.21%	176,244 $12,000
Q3 2023 Nov 14, 2023	BUY	$0.12 - $0.5 $5,118 - $21,326	42,652 New	42,652 $5,000
Q3 2022 Nov 14, 2022	BUY	$1.04 - $322.5 $53,398 - $16.6 Million	51,345 New	51,345 $88,000
Q1 2022 May 16, 2022	SELL	$0.62 - $1.17 $38,957 - $73,516	-62,835 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.89 $29,868 - $51,789	27,402 Added 77.33%	62,835 $68,000
Q3 2021 Nov 15, 2021	BUY	$1.44 - $2.73 $51,023 - $96,732	35,433 New	35,433 $64,000
Q1 2021 May 17, 2021	SELL	$2.82 - $5.6 $34,426 - $68,364	-12,208 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.09 - $3.09 $25,514 - $37,722	12,208 New	12,208 $31,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.